Literature DB >> 8227064

Binding of collagen XIV with the dermatan sulfate side chain of decorin.

B Font1, E Aubert-Foucher, D Goldschmidt, D Eichenberger, M van der Rest.   

Abstract

As an approach to elucidate the role of collagen XIV, which is still unclear, molecules exhibiting affinity for this collagen have been sought in connective tissue. Extracts from fetal bovine tendon were resolved by gel electrophoresis and electrophoretically transferred to nitrocellulose. The blot was overlaid with native collagen XIV and the collagen XIV-binding molecules revealed by immunodecoration with a monoclonal antitype XIV collagen antibody. This experimental approach allowed us to reveal in tendon extracts a diffuse band, with an apparent molecular mass of approximately 100 kDa, that binds collagen XIV. This molecule was also found associated with the fractions containing partially purified type XIV collagen. This 100-kDa molecule was sensitive to chondroitinase ABC and, after chondroitinase digestion, yielded a core protein of about 48 kDa. N-terminal sequence analysis of the proteoglycan after blotting allowed us to identify it as decorin. By solid phase assays we have studied this newly described association between decorin and type XIV collagen and shown that it is a saturable process. In addition, preliminary determination of the domains of the two molecules involved in the association has been performed. The possible role of these interactions is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227064

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Collagen types XII and XIV are present in basement membrane zones during human embryonic development.

Authors:  Laurice Thierry; Andrea Sabine Geiser; Antje Hansen; Florian Tesche; Rainer Herken; Nicolai Miosge
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

2.  Role of decorin in the antimyeloma effects of osteoblasts.

Authors:  Xin Li; Angela Pennisi; Shmuel Yaccoby
Journal:  Blood       Date:  2008-04-24       Impact factor: 22.113

3.  Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.

Authors:  O Okamoto; S Fujiwara; M Abe; Y Sato
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

Review 4.  The "other" 15-40%: The Role of Non-Collagenous Extracellular Matrix Proteins and Minor Collagens in Tendon.

Authors:  Nandaraj Taye; Stylianos Z Karoulias; Dirk Hubmacher
Journal:  J Orthop Res       Date:  2019-08-26       Impact factor: 3.494

5.  Significantly reduced expression of the proteoglycan decorin in Alzheimer's disease fibroblasts.

Authors:  E Brandan; F Melo; M García; M Contreras
Journal:  Clin Mol Pathol       Date:  1996-12

Review 6.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Authors:  Maria A Gubbiotti; Sylvain D Vallet; Sylvie Ricard-Blum; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-30       Impact factor: 11.583

7.  WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair.

Authors:  Dorothy M French; Raji J Kaul; Aloma L D'Souza; Craig W Crowley; Min Bao; Gretchen D Frantz; Ellen H Filvaroff; Luc Desnoyers
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Collagen fibril organization in the pregnant endometrium of decorin-deficient mice.

Authors:  Juliane C T Sanches; Carolyn J P Jones; John D Aplin; Renato V Iozzo; Telma M T Zorn; Sergio F Oliveira
Journal:  J Anat       Date:  2009-11-09       Impact factor: 2.610

9.  Differential gene expression in the perichondrium and cartilage of the neonatal mouse temporomandibular joint.

Authors:  R J Hinton; M Serrano; S So
Journal:  Orthod Craniofac Res       Date:  2009-08       Impact factor: 1.826

Review 10.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.